S3655 – Antisperm antibodies test (immunobead)
HCPCS Level II code · S codes: Temporary National Codes (Non-Medicare)
HCPCS codeS3655
- Long description
- Antisperm antibodies test (immunobead)
- Short description
- Antisperm antibodies test
- Pricing indicator
00Not separately priced by Part B (bundled, not covered or Part A only)- Medicare coverage
INot payable by Medicare- BETOS category
Z2Undefined codes- Added
- October 1, 2002
- Last change
- October 1, 2002 – No change
Frequently asked questions
What is HCPCS code S3655?
S3655 is a HCPCS Level II code for antisperm antibodies test (immunobead).
Does Medicare cover S3655?
The HCPCS file lists coverage code I: Not payable by Medicare. Coverage and payment also depend on local coverage determinations and the patient’s plan.
Nearby S codes
- S3005 – Performance measurement, evaluation of patient self assessment, depression
- S3600 – Stat laboratory request (situations other than s3601)
- S3601 – Emergency stat laboratory charge for patient who is homebound or residing in a nursing facility
- S3620 – Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total)
- S3630 – Eosinophil count, blood, direct
- S3645 – Hiv-1 antibody testing of oral mucosal transudate
- S3650 – Saliva test, hormone level; during menopause
- S3652 – Saliva test, hormone level; to assess preterm labor risk
- S3708 – Gastrointestinal fat absorption study
- S3721 – Prostate cancer antigen 3 (pca3) testing
- S3722 – Dose optimization by area under the curve (auc) analysis, for infusional 5-fluorouracil
- S3800 – Genetic testing for amyotrophic lateral sclerosis (als)
- S3840 – Dna analysis for germline mutations of the ret proto-oncogene for susceptibility to multiple endocrine neoplasia type 2
- S3841 – Genetic testing for retinoblastoma
- S3842 – Genetic testing for von hippel-lindau disease
- S3844 – Dna analysis of the connexin 26 gene (gjb2) for susceptibility to congenital, profound deafness
Source: CMS HCPCS Level II quarterly file, October 2026. Reference only – check payer policy before billing.